Search the Newsreel

Relmada Therapeutics Inc (RLMD) Institutional Confidence

The institutional confidence score for Relmada Therapeutics Inc (RLMD) is 5.00, placing it 132nd out of 386 in the Biotechnology & Medical Research industry. Institutional shareholding stands at 56.47%, marking a significant quarter-over-quarter increase of 184.86%. Steven Cohen is the largest institutional shareholder with …

HP5890612 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the Helmerich & Payne, Inc. bond HP5890612, which has a 4.65% interest rate and matures on December 1, 2027. It details the bond's interest payment overview, stating that the current coupon rate is 4.65% and the next …

Great Elm Group Inc (GEG) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Great Elm Group Inc (GEG), noting its current valuation score is 7.43, ranking 73rd out of 118 in its industry. The company's P/E ratio is -3.08, significantly below its recent high and above its recent low. Key …

Helmerich & Payne, Inc. (HP) Stock Price, News, Quote & History

This article provides comprehensive financial data, news, and historical performance for Helmerich & Payne, Inc. (HP), an oil and gas drilling company. It details the company's stock price, dividend information ($0.25 cash dividend with an ex-date of Aug. 18, 2026), key financial metrics like …

HP|Helmerich and Payne Inc|Price:35.340|Chg%:+0.260

Helmerich and Payne Inc. (HP) shows relatively healthy fundamentals and good growth potential, though its valuation is considered fairly valued within the Oil & Gas Related Equipment and Services industry. Analysts currently rate the stock as "Hold" with a target price of $40.357, suggesting …

Form 144 Helmerich & Payne For: 22 July By Investing.com

This article from Investing.com reports on the filing of Form 144 for Helmerich & Payne (HP) on July 22. Form 144 typically indicates the intent to sell restricted securities. The article provides the title and date of this financial filing.

Great Elm Group Inc. Q2 2026 Earnings: Deep EPS Miss Triggers Stock Reversal - Upward Estimate Revision

WRE.GK Bond Profile — Key Metrics

This article provides key metrics for the WRE.GK bond, issued by Elme Communities. It details the bond's coupon rate, issue and maturity dates, face value, minimum denomination, and a brief description of Elme Communities. The bond, WRE.GK FINRA, has a 3.875% coupon and matures …

2,000,000 Shares in Elme Communities $ELME Purchased by Bulldog Investors LLP

Bulldog Investors LLP acquired a new stake in Elme Communities (NYSE:ELME) during the first quarter, purchasing 2,000,000 shares worth approximately $4.02 million. This investment represents 2.25% of Elme Communities and 0.9% of Bulldog Investors' portfolio. Other institutional investors also increased their holdings in Elme …

Wilh. Wilhelmsen Holding (OB:WWI) Could Be 25% Undervalued As Buybacks And Dividends Support The Story

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. How Wilh. Wilhelmsen Holding Stock Has Been Performing Wilh. Wilhelmsen Holding (OB:WWI) has gained 5.1% over the past month and is up 2.7% in …

Wilh. Wilhelmsen Holding (OB:WWI) Stock Looks Fully Priced After A 403% Five Year Run

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Wilh. Wilhelmsen Holding has delivered a very strong 402.6% return over the past 5 years, yet its current valuation checks suggest the stock …

Great Elm Group (Nasdaq:GEG) - Stock Analysis

This report provides a detailed stock analysis of Great Elm Group (Nasdaq: GEG), an asset management company, highlighting its current market cap of US$67.7 million and a 'Financial Health' snowflake score of 6/6. The analysis points out minor risks such as shareholder dilution and …

Elme Communities (ELME) price target increased by 42.10% to 18.36

This article reports that the price target for Elme Communities (ELME) has been increased by 42.10%, reaching a new target of $18.36. This update suggests a significant positive re-evaluation of the company's stock by analysts.

USU4234PAD3 Bond Risk Profile

This page provides a risk profile for the Helmerich & Payne, Inc. 4.85% 01-DEC-2029 bond (USU4234PAD3), traded on the Frankfurt Stock Exchange. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help users evaluate the bond's …

Helmerich & Payne (HP) Earnings Date and Reports 2026 $HP

Helmerich & Payne (HP) reported its Q2 2026 earnings on May 6, 2026, missing analysts' EPS estimates by $0.32 with -$0.38 per share, and revenue fell short at $932.36 million. The company's Q3 2026 earnings are estimated for August 5, 2026, with an expected …

USU4234PAD3 Bond Profile — Key Metrics

This article provides a bond profile for Helmerich & Payne, Inc.'s 4.85% bond, maturing on December 1, 2029, with the symbol USU4234PAD3. It details key metrics such as the issuer, issue and maturity dates, outstanding amount, face value, and coupon rate. The profile also …

Relmada Therapeutics schedules Q2 2026 financial results call

Relmada Therapeutics has scheduled its Q2 2026 financial results conference call for August 6, 2026, at 4:30 p.m. ET. A webcast of the call will be available at the provided link. This news brief was generated by Public Technologies using AI based on content …

HP6131787 Bond Risk Profile

This page provides a risk profile for the HP6131787 bond issued by Helmerich & Payne, Inc., displaying key metrics for credit risk assessment. It highlights the bond's security level, inflation protection, and issuer rating to help evaluate its reliability. The page also mentions access …

Relmada Therapeutics to announce Q2 2026 financial results

Relmada Therapeutics, Inc. is scheduled to host a conference call and webcast on August 6, 2026, at 4:30 PM ET to discuss its financial results for the second quarter ended June 30, 2026. The clinical-stage biotechnology company will also provide updates on its recent …

Relmada Sets Aug. 6 Call to Discuss Second-Quarter Results

Relmada Therapeutics (Nasdaq: RLMD) will host a conference call and webcast on Thursday, August 6, 2026, at 4:30 PM ET to discuss its financial results for the second quarter ended June 30, 2026, and provide a business update. Investors can join the call via …

(HP) Volatility Zones as Tactical Triggers

This article provides a detailed analysis of Helmerich & Payne Inc. (NYSE: HP), focusing on its volatility zones as tactical triggers for trading strategies. It highlights a near-term strong sentiment, mid-term neutrality, and long-term positive bias, noting elevated downside risk. The analysis includes AI-generated …

Helmerich & Payne, Inc. Schedules Fiscal Third Quarter 2026 Conference Call and Webcast

Helmerich & Payne, Inc. (NYSE: HP) has scheduled a conference call to discuss its fiscal third quarter 2026 results on Thursday, August 6, 2026, at 10 a.m. ET. President and CEO Trey Adams and Senior Vice President and CFO Todd Scruggs will lead the …

Helmerich & Payne to discuss fiscal Q3FY26 results on August 6

Helmerich & Payne, Inc. has scheduled a conference call for August 6, 2026, to discuss its fiscal third-quarter 2026 results. President and CEO Trey Adams and Senior Vice President and CFO Todd Scruggs will lead the call, providing insights into the company's financial performance …

HP6131787 Bond Profile — Key Metrics

This article provides key metrics for the HP6131787 bond issued by Helmerich & Payne, Inc. It details the bond's coupon rate, maturity date, issue date, outstanding amount, and face value. The profile also includes a brief overview of Helmerich & Payne, Inc.'s operations across …

Form 13D/A Great Elm Group For: 14 July By Investing.com

This article reports on a Form 13D/A filing for Great Elm Group dated July 14. The content is brief, primarily serving as an announcement of the filing from Investing.com. It indicates that the filing was made on the specified date.

Helmerich & Payne, Inc. Stock 12‑Month Price Target Cut to $41.29, Implies 22% Upside

Helmerich & Payne, Inc.'s average 12-month price target has been slightly reduced to $41.29 from $41.5 by 14 analysts, with individual forecasts ranging from $30 to $47 per share. This new target suggests a potential upside of approximately 22% based on the July 14 …

OPWV5425405 Bond Profile — Key Metrics

This article provides a bond profile for OPWV5425405, issued by Great Elm Group, Inc. Key metrics include an issue date of June 9, 2022, a maturity date of June 30, 2027, a face value and minimum denomination of 25.00 USD, and a coupon rate …

Great Elm Group (NASDAQ:GEG) Stock Price Down 1.4% - What's Next?

Great Elm Group (NASDAQ:GEG) shares dropped 1.4% on Tuesday, trading on lighter-than-normal volume. The stock currently holds a consensus "Sell" rating, with Weiss Ratings recently downgrading it. The company reported soft financial fundamentals, including a quarterly loss of $0.45 per share and negative return …

USU4234PAE1 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the Helmerich & Payne, Inc. 5.5% 01-DEC-2034 bond (USU4234PAE1). It details the current coupon rate of 5.50% and states that the next payment is scheduled for December 1, 2026. The page also offers features to research bond …

ELME Q4 2025 Earnings: Wider-Than-Expected Loss as Shares Edge Higher - EPS Revision Trend

Elme Communities Actuals & Estimates (NYSE:ELME)

Dunelm Group (LSE:DNLM) Stock Sees Split Analyst Revisions As UK Consumer Data Softens

DNLM Forecast — Price Target — Prediction for 2027

Is There Now An Opportunity In Elementis plc (LON:ELM)?

Elme Communities Q4 2025 Earnings: Significant EPS Miss Overshadowed by Positive Stock Reaction - Buyback Announcement Report

Elme Communities 1Q 2026: Revenue $61.5M, EPS $(0.05) — 10-Q Summary